secwatch.observer — SEC 8-K summary
======================================

Issuer:     Protagonist Therapeutics, Inc (PTGX)
CIK:        0001377121
Form:       8-K
Filed at:   2023-05-30T23:59:59+00:00
Accession:  0001104659-23-066057
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Annual meeting results: Patel elected, compensation and auditor approved
------------------------------------------------------------------------

- Elected Dinesh V. Patel as Class I director with 32,660,198 for, 8,874,076 withheld, 3,298,693 broker non-votes.
- Advisory executive compensation approved: 39,838,516 for, 1,673,050 against, 22,708 abstentions, 3,298,693 broker non-votes.
- Ratified Ernst & Young as independent auditor for FY2023: 44,807,871 for, 15,794 against, 9,302 abstentions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1377121/000110465923066057/0001104659-23-066057-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1377121/000110465923066057/tm2317329d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-066057

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer